Page 10 of 43
A. Challenges
Four broad challenges were identified. First, 'technical considerations, including: the absence
of mental health from the current NCD priorities; the branding of NCDs; and the fact that
risk factors for some NCDs are in fact infectious in nature. Greater clarity on these issues
will be helpful as will specific guidance on strengthening health systems.
The second was the need for governments to fully understand and commit to the NCDs
agenda and to commit resources to dealing with NCD prevention and control. Third were
the health systems challenges, including access to and affordability of services. Finally,
commercial interests and how they interact in this space was identified as a challenge, but
also an opportunity.
B. Outcomes
The first desirable outcome identified in this concurrent session was funding and resources
for NCD prevention and control; these include indigenous sources including taxes and
innovative means as well as potentially development funding. Second was the structural
response, including appropriate governance and leadership arrangements and mobilizing
partnerships with the full range of stakeholders such as patient and community groups.
There is an opportunity to harness the new social media to engage a wider community in
support of NCD prevention and control.
The third outcome being called for was time-based indicators and targets and a mechanism
for monitoring them. Fourth was 'normative clarity' around the relationships with
communicable diseases and the health systems response to provide more specific guidance
to governments on how to do this. Finally, attitudinal change is needed in the public health
community to ensure appropriate engagement with the private sector. Consumers also need
to be supported to change their attitudes towards the risk factors for NCDs.
C. Commitments and priorities
There was an exciting discussion that elicited a range of significant commitments from those
present including professional bodies, faith-based organizations, NGOs. A number of
examples were provided of specific commitments that covered awareness raising, helping to
identify targets, mobilizing membership networks, developing training programs on NCDs
for leaders, capacity building, strengthening the consumer response to NCDs, integrating
NCD prevention and treatment into existing services such as maternal and child health,
service development and mobilizing political leadership. It was noted that the role of Civil
Society organizations is to assist and support governments and States, which have the
primary responsibility for NCD prevention and control.
Concurrent session 5 Researchers and academia
Dr Abdallah Daar, Chair of the Global Alliance for Chronic Diseases, chaired this session.
The main presentation reminded participants that we have sufficient research evidence to act
decisively on NCDs, but that we need better research evidence on how to intervene more
Page 11 of 43
effectively.
11
The current research challenges and proposed responses for NCD policy and
practice were reviewed.
The following is a summary of the discussion.
A. Challenges
Much is known about the size and causes of the problem, but more is needed on the details
in particular country and region specific data – this requires surveillance to guide investment
by governments. There is improving evidence from implementation research that supports
translating knowledge into action, but this is currently underfunded and is a high priority for
further investment. Likewise, we are in the 'infancy' of integrating the science into policy
action, e.g. the WHO Framework Convention on Tobacco Control (FCTC) is only partially
implemented despite wide ratification. More information is needed on what is modifiable in
different countries, as this is strongly related to social and cultural influences.
While health services 'own' the diseases, they don't own the causes as these are
environmental and social. Thus, there is a problem with the 'ownership' of prevention:
effective prevention is effectively invisible. Research needs to also look at intergenerational
effects ie fetal and newborn development - and research into preventing prolonged
morbidity, which is a big driver of costs.
B. Outcomes
A desirable outcome is a wider commitment and investment in the nascent international
collaboration for funding of culturally-specific research, which has an initial tranche of
funding available for implementation research. Further investment in surveillance will be
critical, especially to strengthen surveillance in developing countries. A better understanding
of the size and epidemic nature of the problem, ie that it is reversible will be crucial to ensure
that the necessary investment is made now to prevent a huge and costly potential problem
The 'knowledge pool' is bigger than just the published scientific articles and includes the
accumulated experience of governments and other parts of society: mechanisms for sharing
this knowledge need to be further developed.
C. Commitments and priorities
The Global Alliance for Chronic Disease is an existing commitment by a number of
governments in global health research on NCDs, and it will be important to widen the pool
of Governments supporting and contributing funding. A key priority is coordinating the
disparate groups of stakeholders, including universities, to address the research gaps and
foster emerging researchers. Governments also need to invest in health systems research, in
particular to work out how to integrate NCD prevention and control into health service
delivery.
11
The presentation of Dr Reddy is available at:
http://www.who.int/nmh/events/global_forum_ncd/documents/session_5_research_srinath_reddy.pdf